NiQuitin Strips Mint 2.5mg Oral Film

Kraj: Wielka Brytania

Język: angielski

Źródło: myHealthbox

Składnik aktywny:

nicotine

Dostępny od:

Omega Pharma Ltd

Kod ATC:

N07BA01

INN (International Nazwa):

nicotine

Dawkowanie:

2.5 mg

Forma farmaceutyczna:

Orodispersible Film

Droga podania:

on the tongue

Sztuk w opakowaniu:

10, 15, 30 or 60 sachets

Typ recepty:

GSL - General Sales List

Wyprodukowano przez:

Lohmann Therapie- Systeme AG

Grupa terapeutyczna:

Drugs used in nicotine dependence

Wskazania:

NiQuitin Strips relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. They are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. NiQuitin Strips are indicated in pregnant and lactating women making a quit attempt. NiQuitin Strips should preferably be used in conjunction with a behavioural support programme.

Status autoryzacji:

Authorised

Data autoryzacji:

2015-12-23

Ulotka dla pacjenta

The Marketing Authorisation Holder is Omega Pharma Ltd, 32 Vauxhall
Bridge Road, 
London, SW1V 2SA, UK and all enquiries should be sent to this address.
NIQUITIN is a registered trade mark of ELAN PHARMA INTERNATIONAL LTD
This leaflet was prepared in October 2015.

Charakterystyka produktu

1L4XLWLQ6WULSVPJ2UDO)LOP
6XPPDU\RI3URGXFW&KDUDFWHULVWLFV8SGDWHG$SU_2PHJD3KDUPD/WG
1DPHRIWKHPHGLFLQDOSURGXFW
1L4XLWLQ6WULSV0LQWPJ2UDO)LOP
4XDOLWDWLYHDQGTXDQWLWDWLYHFRPSRVLWLRQ
(DFKRURGLVSHUVLEOHILOPFRQWDLQVPJQLFRWLQH
&RQWDLQVHWKDQROQRPRUHWKDQPJSHUILOP
)RUIXOOOLVWRIH[FLSLHQWVVHHVHFWLRQ
3KDUPDFHXWLFDOIRUP
2URGLVSHUVLEOH)LOP
7UDQVSDUHQWILOPDSSUR[LPDWHO\PPE\PP
&OLQLFDOSDUWLFXODUV
7KHUDSHXWLFLQGLFDWLRQV
1L4XLWLQ6WULSVUHOLHYHDQGRUSUHYHQWFUDYLQJDQGQLFRWLQHZLWKGUDZDOV\PSWRPVDVVRFLDWHGZLWKWREDFFRGHSHQGHQFH
7KH\DUHLQGLFDWHGWRDLGVPRNHUVZLVKLQJWRTXLWRUUHGXFHSULRUWRTXLWWLQJWRDVVLVWVPRNHUVZKRDUHXQZLOOLQJRU
XQDEOHWRVPRNHDQGDVDVDIHUDOWHUQDWLYHWRVPRNLQJIRUVPRNHUVDQGWKRVHDURXQGWKHP
1L4XLWLQ6WULSVDUHLQGLFDWHGLQSUHJQDQWDQGODFWDWLQJZRPHQPDNLQJDTXLWDWWHPSW
1L4XLWLQ6WULSVVKRXOGSUHIHUDEO\EHXVHGLQFRQMXQFWLRQZLWKDEHKDYLRXUDOVXSSRUWSURJUDPPH
3RVRORJ\DQGPHWKRGRIDGPLQLVWUDWLRQ
_'LUHFWLRQVIRUXVH_
1L4XLWLQ6WULSVDUHVXLWDEOHIRUVPRNHUVZKRKDYHWKHLUILUVWFLJDUHWWHRIWKHGD\PRUHWKDQPLQXWHVDIWHUZDNLQJXS
3ODFHRQHILOPRQWKHWRQJXH&ORVHWKHPRXWKDQGSUHVVWKHWRQJXHJHQWO\WRWKHURRIRIWKHPRXWKXQWLOWKHQLFRWLQH
ILOPGLVVROYHVDSSUR[LPDWHO\PLQXWHV7KHILOPVKRXOGQRWEHFKHZHGRUVZDOORZHGZKROH
8VHUVVKRXOGQRWHDWRUGULQNZKLOHDQLFRWLQHILOPLVLQWKHPRXWK
%HKDYLRXUDOWKHUDS\DGYLFHDQGVXSSRUWZLOOQRUPDOO\LPSURYHWKHVXFFHVVUDWH
$GXOWV\HDUVDQGRYHU
_$EUXSWFHVVDWLRQRIVPRNLQJ_
8VHUVVKRXOGPDNHHYHU\HIIRUWWRVWRSVPRNLQJFRPSOHWHO\GXULQJWUHDWPHQWZLWK1L4XLWLQ6WULSV
_5HFRPPHQGHGWUHDWPHQWVFKHGXOH_
6WHS
:HHNVWR
6WHS
:HHNVWR
6WHS
:HHNVWR
,QLWLDOWUHDWPHQWSHULRG
6WHSGRZQWUHDWPHQWSHULRG
6WHSGRZQWUHDWPHQWSHULRG
QLFRWLQHILOPHYHU\WRKRXUV
QLFRWLQHILOPHYHU\WRKRXUV
QLFRWLQHILOPHYHU\WRKRXUV
'XULQJZHHNVWRLWLVUHFRPPHQGHGWKDWXVHUVWDNHDPLQL